Fig. 8: Prediction of clinical groups and symptoms across APOE genotyping groups. | Communications Biology

Fig. 8: Prediction of clinical groups and symptoms across APOE genotyping groups.

From: Individual-specific functional connectivity improves prediction of Alzheimer’s disease’s symptoms in elderly people regardless of APOE ε4 genotype

Fig. 8: Prediction of clinical groups and symptoms across APOE genotyping groups.The alt text for this image may have been generated using AI.

a The AUCs for APOE ε4 carriers versus APOE ε4 noncarriers for the 5-fold cross-validation in NA (42 APOE ε4 carriers versus 43 APOE ε4 noncarriers), MCI (39 APOE ε4 carriers versus 39 APOE ε4 noncarriers), and AD groups (39 APOE ε4 carriers versus 33 APOE ε4 noncarriers), respectively. b Functional connectivity was not able to estimate the MMSE scores in the elderly participants across two APOE genotypes (N = 235). c Functional connectivity was also not able to estimate the LIMM scores in the cross-genetic cohort (N = 235).

Back to article page